EMSTER KURT VON
Insider CIK 1252524 · CBAY Director · SOMX Director · PCVX Director · CRSP Director · JSPR Director, 10% owner · VERA Director, 10% owner · IAM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IAM Iambic Therapeutics, Inc. | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-07-03 | 2025-07-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,705 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 49,245 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 16,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 90,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-29 | 2023-09-29 | 943 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-29 | 2023-09-29 | 3,372 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-29 | 2023-09-29 | 5,249 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-29 | 2023-09-29 | 6,357 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-29 | 2023-09-29 | 15,921 | $15.68 | $249.6K | 90,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-29 | 2023-09-29 | 15,921 | $5.00 | $79.6K | 105,921 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 47,000 | — | $0 | 47,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | S Sale | 2023-04-13 | 2023-04-14 | 9,075 | $1.49 | $13.5K | 21,175 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award | 2022-10-12 | 2022-10-13 | 30,250 | — | $0 | 30,250 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 78,045 | — | $0 | 78,045 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 67,000 | — | $0 | 67,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 772,727 | $11.00 | $8.50M | 2,960,231 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-17 | 2021-05-18 | 17,828 | $12.04 | $214.6K | 17,828 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2021-05-13 | 2021-05-17 | 9,925 | — | $0 | 9,925 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-02-01 | 32,000 | — | $0 | 32,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 1,217,074 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 2,185,415 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 298,917 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 454,812 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 1,217,074 | — | $0 | 3,402,489 | SEC↗ |
| PCVX Vaxcyte, Inc. | P Buy | 2020-06-16 | 2020-06-18 | 12,500 | $16.00 | $200.0K | 4,168,718 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 454,812 | — | $0 | 3,857,301 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 298,917 | — | $0 | 4,156,218 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 2,185,415 | — | $0 | 2,185,415 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-06-23 | 49,245 | — | $0 | 49,245 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 27,705 | — | $0 | 27,705 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-12-18 | 2019-01-18 | 62,925 | $29.70 | $1.87M | 1,171,268 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-12-18 | 2018-12-19 | 53,492 | $7.43 | $397.4K | 131,036 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-12-18 | 2018-12-19 | 69,925 | $29.70 | $2.08M | 1,164,268 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-12-17 | 2018-12-19 | 88,889 | $8.17 | $726.2K | 184,528 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-12-17 | 2018-12-19 | 3,009 | $33.17 | $99.8K | 1,234,193 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-06-15 | 2018-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | X Exercise deriv | 2018-06-05 | 2018-06-07 | 2,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | X Exercise deriv | 2018-06-05 | 2018-06-07 | 2,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | X Exercise deriv | 2018-06-05 | 2018-06-11 | 2,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-06-05 | 2018-06-07 | 920 | $12.51 | $11.5K | 18,316 | SEC↗ |
| CRSP CRISPR Therapeutics AG | X Exercise | 2018-06-05 | 2018-06-07 | 2,000 | $5.75 | $11.5K | 19,236 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-06-05 | 2018-06-07 | 920 | $12.51 | $11.5K | 18,316 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | X Exercise | 2018-06-05 | 2018-06-07 | 2,000 | $5.75 | $11.5K | 19,236 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-06-05 | 2018-06-11 | 920 | $12.51 | $11.5K | 18,316 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | X Exercise | 2018-06-05 | 2018-06-11 | 2,000 | $5.75 | $11.5K | 19,236 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-14 | 2018-05-15 | 20,881 | $52.93 | $1.11M | 1,246,102 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-14 | 2018-05-15 | 53,927 | $53.86 | $2.90M | 1,266,983 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-14 | 2018-05-15 | 126,901 | $54.99 | $6.98M | 1,320,910 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-14 | 2018-05-15 | 73,144 | $55.72 | $4.08M | 1,447,811 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-14 | 2018-05-15 | 116,247 | $56.90 | $6.61M | 1,520,955 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-14 | 2018-05-15 | 8,900 | $52.20 | $464.6K | 1,237,202 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-11 | 2018-05-15 | 127,890 | $52.46 | $6.71M | 1,645,835 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-11 | 2018-05-15 | 8,633 | $51.73 | $446.6K | 1,637,202 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-11 | 2018-05-15 | 113,477 | $53.36 | $6.06M | 1,773,725 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-03-05 | 2018-03-07 | 13,353 | $15.51 | $207.1K | 273,417 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-15 | 2018-02-20 | 68,712 | $14.49 | $995.6K | 286,770 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-14 | 2018-02-15 | 162,979 | $16.69 | $2.72M | 355,482 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-14 | 2018-02-16 | 162,979 | $13.69 | $2.23M | 355,482 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-13 | 2018-02-15 | 55,078 | $13.51 | $744.1K | 518,461 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-07 | 2018-02-09 | 40,763 | $12.35 | $503.4K | 419,693 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-05 | 2018-02-07 | 18,831 | $12.14 | $228.6K | 460,456 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-02 | 2018-02-05 | 2,000 | $12.11 | $24.2K | 479,287 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-02-01 | 2018-02-05 | 88,098 | $12.15 | $1.07M | 481,287 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-31 | 2018-02-01 | 12,300 | $12.23 | $150.4K | 569,385 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-30 | 2018-02-01 | 85,339 | $12.22 | $1.04M | 581,685 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-25 | 2018-01-26 | 39,438 | $12.18 | $480.4K | 667,024 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-22 | 2018-01-24 | 138,253 | $10.40 | $1.44M | 706,462 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-19 | 2018-01-22 | 130,584 | $10.25 | $1.34M | 844,715 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-18 | 2018-01-22 | 13,632 | $10.21 | $139.2K | 975,299 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-01-05 | 2018-01-09 | 4,300 | $10.21 | $43.9K | 988,931 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-01-05 | 2018-01-09 | 92,337 | $26.96 | $2.49M | 1,821,268 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2018-01-05 | 2018-01-11 | 65,934 | $22.75 | $1.50M | 1,887,202 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-01-02 | 2018-01-04 | 37,754 | $26.76 | $1.01M | 1,913,605 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-12-22 | 2017-12-27 | 173,192 | $9.41 | $1.63M | 993,231 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-11-10 | 2017-11-14 | 50,048 | $9.26 | $463.4K | 1,166,423 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-11-01 | 2017-11-03 | 4,320 | $9.25 | $40.0K | 1,216,471 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-10-31 | 2017-11-01 | 52,573 | $9.27 | $487.4K | 1,220,791 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-10-30 | 2017-11-01 | 6,636 | $9.26 | $61.4K | 1,273,364 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-10-03 | 2017-10-04 | 70,940 | $7.81 | $554.0K | 1,280,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-10-02 | 2017-10-04 | 37,936 | $7.93 | $300.8K | 1,350,940 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-09-29 | 2017-10-02 | 120,735 | $8.04 | $970.7K | 1,388,876 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2017-09-28 | 2017-10-02 | 90,389 | $8.15 | $736.7K | 1,509,611 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-28 | 2017-08-30 | 88,011 | $19.79 | $1.74M | 1,951,359 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-25 | 2017-08-28 | 14,913 | $19.52 | $291.1K | 2,039,370 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-24 | 2017-08-28 | 7,868 | $19.23 | $151.3K | 2,054,283 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-23 | 2017-08-24 | 7,035 | $18.53 | $130.4K | 2,062,151 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-22 | 2017-08-24 | 10,954 | $18.53 | $203.0K | 2,069,186 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-21 | 2017-08-22 | 1,250 | $18.51 | $23.1K | 2,080,140 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-18 | 2017-08-22 | 1,900 | $18.53 | $35.2K | 2,081,390 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-17 | 2017-08-18 | 13,593 | $18.74 | $254.7K | 2,083,290 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-16 | 2017-08-18 | 20,548 | $19.27 | $396.0K | 2,096,883 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-15 | 2017-08-16 | 25,586 | $19.53 | $499.7K | 2,117,431 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-14 | 2017-08-16 | 29,983 | $19.64 | $588.9K | 2,143,017 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-08 | 2017-08-09 | 19,850 | $18.71 | $371.4K | 2,190,872 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-07 | 2017-08-09 | 15,623 | $18.53 | $289.5K | 2,210,722 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-04 | 2017-08-07 | 3,068 | $18.50 | $56.8K | 2,226,345 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-03 | 2017-08-07 | 47,409 | $17.77 | $842.5K | 2,229,413 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-01 | 2017-08-02 | 264 | $17.50 | $4.6K | 2,276,822 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-31 | 2017-08-02 | 5,248 | $17.51 | $91.9K | 2,277,086 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-28 | 2017-07-31 | 400 | $17.65 | $7.1K | 2,282,334 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-27 | 2017-07-31 | 40,912 | $17.63 | $721.3K | 2,282,734 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-26 | 2017-07-27 | 23,744 | $17.63 | $418.6K | 2,323,646 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-25 | 2017-07-27 | 9,186 | $17.52 | $160.9K | 2,347,390 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-19 | 2018-02-12 | 153,846 | $6.50 | $1000.0K | 1,753,846 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-14 | 2017-07-17 | 36,230 | $16.82 | $609.4K | 2,356,576 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-13 | 2017-07-17 | 33,629 | $16.87 | $567.3K | 2,392,806 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-12 | 2017-07-13 | 17,872 | $16.60 | $296.7K | 2,408,563 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-11 | 2017-07-13 | 14,120 | $16.52 | $233.3K | 2,426,435 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-07-05 | 2017-07-07 | 4,254 | $16.26 | $69.2K | 2,440,555 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-29 | 2017-06-30 | 11,610 | $16.52 | $191.8K | 2,444,809 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-28 | 2017-06-30 | 31,592 | $17.04 | $538.3K | 2,456,419 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-27 | 2017-06-28 | 33,434 | $17.43 | $582.8K | 2,488,011 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-26 | 2017-06-28 | 48,001 | $16.83 | $807.9K | 2,521,445 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-23 | 2017-06-26 | 30,841 | $16.23 | $500.5K | 2,569,446 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-22 | 2017-06-26 | 1,527 | $16.21 | $24.8K | 2,600,287 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion deriv | 2016-10-24 | 2017-02-10 | 191,764 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion deriv | 2016-10-24 | 2017-02-10 | 2,354,050 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion | 2016-10-24 | 2017-02-10 | 2,354,050 | — | $0 | 2,354,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion | 2016-10-24 | 2017-02-10 | 191,764 | — | $0 | 2,545,814 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2016-10-24 | 2017-02-10 | 56,000 | $14.00 | $784.0K | 2,601,814 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2016-10-18 | 2016-10-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 31,800 | — | $0 | 0 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 3,214 | — | $0 | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 6,541 | — | $0 | 27,679 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 48,103 | — | $0 | 169,105 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-09-05 | 2012-09-06 | 1,367 | $0.29 | $396 | 25,712 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 61,579 | — | $0 | 121,002 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award deriv | 2012-05-31 | 2012-06-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-04-02 | 2012-04-04 | 59,423 | — | $0 | 59,423 | SEC↗ |